Skip to main content
Fig. 3 | Parasites & Vectors

Fig. 3

From: Efficacy of Bravecto® Plus spot-on solution for cats (280 mg/ml fluralaner and 14 mg/ml moxidectin) for the prevention of aelurostrongylosis in experimentally infected cats

Fig. 3

Lung pathology score in the four study groups at the day of necropsy (47-50 dpi, SD 131-134). G1: treatment 12 weeks before experimental infection, G2: treatment 8 weeks before experimental infection, G3: treatment 4 weeks before experimental infection, G4: control group. The asterisks indicate statistically significant differences in pathology scores between the control (G4) and the treatment (G1–G3) groups

Back to article page

Parasites & Vectors

ISSN: 1756-3305

Contact us